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Abstract
Background: Every year in Europe 60,000 women develop cervical cancer and 30,000 die from the disease. HPV
vaccines are currently believed to constitute an important element of cervical cancer control strategy. Currently in
Greece, the HPV vaccine is given on demand after prescription by a healthcare professional. Health care professionals’
role is key as they are in a position to discuss HPV vaccination with parents, adolescents and young women. This study
is aiming to explore health care professionals’ perceptions of the HPV vaccine, state policy recommendations and their
own role with regards to communication of relevant health information.
Methods: This was an in-depth, qualitative study, employing a stratified, purposeful sampling. Fifteen face-to-face,
semi-structured interviews were conducted with health care professionals from a variety of disciplines: pediatrics,
obstetrics and gynecology, infectious diseases, pharmacy, dermatology, general practice. Thematic qualitative analysis
was used to analyze participants’ accounts.
Results: Five major themes were identified: health care professionals’ perceptions towards the HPV vaccine
(recognition of importance, concerns about safety, effectiveness and impact of long-term use), animosity
between medical specialties (territorial disputes among professional bodies, role advocacy, role limitations),
health care professionals’ perceptions of the public’s attitudes (effects of cultural beliefs, health professionals’
attitudes, media and family), the role of the state (health policy issues, lack of guidance, unmet expectations)
and their own role (provision of health information, sex education).
Conclusions: Health professionals’ concerns, lack of role definition and uniform information provision have
led to territorial disputes among professional bodies and distrust among different medical specialties. Positive
and negative judgements deriving from a multitude of sources have resulted in the confusion of the general
public, as manifested by low vaccination rates. Due to the lack of clear regulation of vaccination prescription,
administration and mode of delivery, factors such as lack of knowledge, cultural beliefs and personal attitudes
have shaped the vaccination landscape. These factors have neither been explored nor addressed prior to the
initiation of this public health effort and as such there is an evident less than efficient use of resources.
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Background
Every year in Europe 60,000 women develop cervical
cancer (cc) and 30,000 die from the disease [1]. Cervical
cancer has a younger age of onset compared to other
adult cancers and currently ranks as the second most
frequent cancer in European women between 15 and
44 years of age [1]. Cytology based screening programs
constitute the main tool for detecting precancerous
abnormalities and early stages of cancer which if treated
can result in a 80 % prevention of cervical cancers [2].
Complementary to secondary prevention, cervical cancer
prevention can additionally take place on a primary pre-
vention level, following the recent introduction of the two
vaccines against Human Papilloma Virus (HPV), a family
of viruses that are extremely common worldwide and are
estimated to cause 100 % of cervical cancer cases [2]. HPV
vaccines are currently believed to constitute an important
element of cervical cancer control strategy and thus a
response to a critical public health need [2]. The World
Health Organization stresses that ‘ensuring universal
access to HPV vaccination, screening and treatment
services will be key to reducing the burden of cervical
cancer worldwide’ [2].
According to the European Cervical Cancer Association
(ECCA) 2009 report, recommendations for HPV vaccin-
ation vary across European countries. Certain countries
have established or plan to establish school vaccination
programs such as the UK, Norway, Sweden, Belarus and
Romania while others offer some variation of the ‘on
demand’ vaccination plan such as France, Germany,
Luxemburg, Portugal, some regions of Spain and Greece.
In Greece, the recommendations for HPV vaccination
were put together in 2008 by the Ministry of Health and
Social Solidarity after appropriate suggestions from the
National Vaccination Committee [3]. Currently, the HPV
vaccine may be prescribed to girls aged 12 to 18 years
by physicians in the specialty of Pediatrics, Obstetrics-
Gynecology, General Practice and Pathology. For ages
18 to 26 years, the vaccine may be prescribed by medical
specialties of Obstetrics - Gynecology, General Practice,
Pathology and Dermatology or Venereology [4]. Currently
there are two vaccines available: GARDASIL, a qua-
drivalent vaccine against HPV types 16, 18, 6, 11 and
CERVARIX, against HPV types 16 and 18.
Preliminary evaluations show that school-based vaccin-
ation programmes tend to achieve higher coverage com-
pared to on demand vaccination provision, even if this is
supported by health professionals’ direct invitation or pub-
lic education programmes [3]. Statistical data reveal 92 %
coverage in Scotland and 90 % in Spanish regions where
HPV vaccination is delivered through a school program
while on demand vaccination supported by invitation and
public education efforts puts coverage at approximately
50 % in the Netherlands and lower than 50 % in Spanish
regions where provision on demand is not supported by
educational activities [3]. In summary, countries which
offer HPV vaccination on demand tend to achieve sub-
optimal coverage rates with lower socioeconomic groups
and minorities being at a disadvantage, thus perpetuating
health inequalities [3].
In Greece, recently conducted research studies have
revealed that the incidence of HPV infection can range
from 22.7 %, as found in a sample of 225 women attend-
ing an outpatient gynecology clinic [5] up to 50.7 %, as
found in a large epidemiological study in a sample of
2952 women [6]. However, HPV vaccination coverage
has been shown to be very low among female students
25.8 % from various disciplines (n = 3.153) and relatively
low 44.3 % even among female higher education students
(n = 865) in medicine, nursing and allied health profes-
sional study programs [7], who as aspiring health profes-
sionals are in an advantageous position with regards to
comprehending the need for the adoption of a health
innovation [8]. Furthermore, the vaccination coverage per-
centage is even lower among Greek adolescents, namely
11.9 % [9].
With regards to the factors affecting Greek women’s
intention to get vaccinated or to vaccinate their children,
research shows that receiving information from a health
care professional positively affected intention to self-
vaccinate [10] while factors such as: younger age, higher
educational level, previous visits to the gynecologist,
consistent condom use, easy access to healthcare, non-
smoking status and single relationship status, constituted
positive predictors of vaccination [8]. As far as the reasons
for declining vaccination are concerned, women have
listed ‘fear of vaccine safety’ as the main reason and more-
over were less likely to vaccinate if they had received
information from the mass media compared to other
sources (e.g. Hellenic Center for Disease Control and
Prevention) [7]. In contrast, women’s main reason for
declining vaccination was initially ‘insufficient knowledge’,
however this was later substituted by ‘fear of vaccination
adverse events’ [10]. Interestingly, this change occurred
after the introduction of the vaccine, and coincided with
negative media publicity [10].
The role health care professionals’ in communicating
health information concerning the HPV vaccine and in
shaping parental, adolescent and young women’s attitudes
towards the said vaccination has been highlighted in the
international literature [11–15]. For the majority of the
general public, health care providers still constitute a for-
mal source of information regarding any health issue while
they are also an important advocacy group with scientific
status and presence in the media [16].
The acceptance of the vaccines is of paramount import-
ance when it comes to the successful implementation of
HPV vaccination programs. Both adolescents who are the
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primary target group and their parents who are the
decision makers need to see the vaccine in a positive light
so that uptake but also adherence to all three doses is
ensured [11]. Specifically, findings of a Danish study [12]
revealed that young women (16–26) listed recommenda-
tion by a health care professional among the reasons for
HPV vaccination along with prevention of cervical cancer,
parental encouragement and being close to someone with
cancer. According to a review of the US literature [13]
parents were more likely to opt for vaccination after
receiving a recommendation from a health care profes-
sional which influenced young adolescent girls’ vaccin-
ation decision. Furthermore, interactions between health
professionals and parents play a major role in forming par-
ental attitudes towards vaccination [14]. Finally, findings of
a French study [15] suggest that health professionals have a
significant role to play in information provision as they are
in a unique position to discuss with the target population
barriers to acceptance.
The exploration of health care professionals’ percep-
tions is particularly salient in countries where HPV
vaccines are provided on demand after prescription. To
the best of our knowledge, there have been no research
studies to date investigating perceptions of health care
professionals in Greece since the release of the HPV
vaccine in 2008. Specifically, the current study is aiming
to explore the following research questions:
Q1. What are health care professionals’ perceptions
towards the HPV vaccine?
Q2. What are health care professionals’ perceptions
towards state policy recommendations?
Q3. What are health care professionals’ perceptions of




This was an in-depth, qualitative study. Fifteen face-
to-face, semi-structured interviews were conducted with
health care professionals. A stratified, purposeful sampling
was employed to include participants from a variety of dis-
ciplines relating to HPV infection, HPV vaccination and
cervical cancer. Patton [17] describes stratified samples as
samples within samples and suggests that purposeful
samples can be stratified or nested by selecting particular
units or cases that vary according to a key dimension. In
this case the sample was stratified in that participants
varied according to discipline/ specialty. A maximum of
three participants were selected from each relevant discip-
line, resulting to a total sample of 15. The sample was also
purposeful as sample participants were recruited through
key institutions which the investigators’ thought ought to
be present in the sample namely the two largest medical
schools in the country University of Athens & University
of Thessaloniki, the National School of Public Health and
the Hellenic Center for Diseases Control and Prevention
(KELPNOO).
Materials
The interview schedule consisted of 26 open-ended ques-
tions which covered topics such as the health professionals’
perceptions of the HPV vaccine (e.g. effectiveness, safety),
state policy recommendations (e.g. mode of delivery),
health information sources (state, professionals, media),
modes of health information communication, vaccination
decision making, sexual health education, adolescent
sexual behavior, perceptions of public’s and health pro-
fessionals’ beliefs. The interview schedule was developed
after identification of key issues of interest through a
thorough literature search as well as attendance of rele-
vant educational meetings and conferences (i.e. meeting
of the Greek HPV society in Thessaloniki, 2012).
Participants
Health care professionals came from a range of spe-
cialties such as: pediatrics, obstetrics and gynecology,
infectious diseases, pharmacy, dermatology and general
practice. Five participants were female and ten were male.
Their age ranged from 34 to 65 years. All participants
worked full time and the majority additionally owned their
own private practice. Pharmacists were an exception as
they all owned community pharmacies, a very common
occurrence in Greece.
Procedure
Participants were recruited from a variety of different
contexts, namely hospitals, universities and organizations
and were invited to participate over the phone. None of
the invited participants approached refused to participate.
An appointment for the interview was arranged after the
nature and aim of the study was explained and informed
consent was obtained. The interviews took place in a pri-
vate office in each participant’s workplace, lasted approxi-
mately 30 to 40 min and were conducted by the principal
investigator (CK), who is a health psychologist. The inter-
views were conducted in the Greek language, were audio
recorded and transcribed verbatim. For confidentiality
purposes, participant names were replaced by an abbrevi-
ated version of their discipline and their age (Please see list
of abbreviations at the end of the manuscript). The Greek
General Secretariat for Science and Technology (GSRT),
the public body which funded the current study, allocated
its evaluation to independent international reviewers/
experts through a system of blind reviewing. These
international experts among other criteria, reviewed the
study aim, design and materials according to the principles
included in the manual entitled ‘Ethics for Researchers’, of
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the European Commission, issued for the 7th Framework
Programme (FP7), and approved it without raising any
ethical and/or other considerations. Furthermore, following
review of the study the University of Peloponnese, School
of Social and Political Sciences Research Ethics Committee
confirmed that it did not require ethics approval and
was in full accordance with the current Research Ethics
guidelines.
Analysis
The audio-recordings were transcribed in Greek and
analyzed in the Greek language by both investigators
separately. Findings were then compared and an agree-
ment on the final themes was reached. Specific quotes
and theme titles were subsequently translated in English
by the principal investigator (CK). A separate translation
was conducted by an Applied Linguist with an MA
qualification. Disagreements on terminology and choice
of wording were negotiated and resolved. This method
i.e. translation by two separate translators has been sug-
gested by cross-cultural researchers such as Esposito
[18]. Furthermore, according to recommendations by
van Nes et al. [19] in order to reduce the loss of meaning
and thereby enhance the validity of cross-English quali-
tative research, researchers should stay in the original lan-
guage ‘as long and as much as possible’. The reason for
this is that thinking and language are closely related and
thus analysis may be influenced if conducted in a language
different other the researchers’ own. Finally, according to
a review on social research translation issues [20] among
the factors affecting the quality of translation in those
cases, where the researcher and the translator are the
same person, are: the autobiography of the researcher-
translator; the researcher’s knowledge of the language and
the culture of the people under study and the researcher’s
fluency in the language of the write-up. In the present
case, both investigators are Greek, hold PhD degrees, were
educated in UK and have experience in conducting quali-
tative research. The investigators were reflective about the
design, conduct and analysis of this study. A number of
strategies were employed to enhance credibility of the
research findings such as ‘acknowledging biases in sam-
pling, using investigator triangulation, seeking out similar-
ities and differences across accounts to ensure different
perspectives are represented and including rich and thick
verbatim descriptions of participants’ accounts to support
findings’ [21].
Thematic qualitative analysis [22] was used to analyze
participants’ accounts. After familiarization with the
data, initial codes were generated. Themes were iden-
tified, reviewed and defined. Finally, these were ana-
lyzed and supported with extracts from participants’
accounts.
Results
Some of the most prominent themes that emerged from
participants’ accounts were the following:
Health professionals’ perceptions of the HPV vaccine
The majority of participants considered the HPV vaccine
‘an amazing innovation’ (PED, 65), described it as ‘…one
of the most important vaccines of the last ten, fifteen
years… (ID, 53) and prescribed it to their patients ‘I
think it is one of the most effective vaccines which have
brought change in the area of infections….change in the
sense that a very common cancer can be prevented… very
few vaccines are related to cancer prevention. Based on
this, I consider it’s really important and I recommend it’
(ID, 47).
However, some participants felt there were still issues
to consider such as, in one participant’s words: ‘It is a
relatively new vaccine, which means that we can’t be
100 % certain about what it does, its effectiveness or
whether it has any adverse effects…’ (ID, 40). Addition-
ally, some participants had specific concerns pertaining
to the HPV vaccine and the long-term effects of its
wider use: ‘Yes, it is a new vaccine…. studies that have
been conducted are retrospective, not prospective…so who
knows what will happen after twenty years…the technology
of production… with a modified protein..I don’t know what
kind of effects it might have in auto-immune type illnesses
…the virus has too many types…the vaccine only two, the
other four…I wonder with natural selection fifteen, twenty
years after mass vaccination, if other types will prevail as
it has happened with other vaccines’ (PED, 55). These
concerns naturally affected health professionals’ behavior
and in some cases gave rise to conflicting advice towards
the public: ‘We administer it but we do not recommend
it’ (PH, 34).
Animosity among medical specialties
Another strong theme that emerged from the data was
the evident animosity among medical specialties. Since
the introduction of the HPV vaccine, professional bodies
representing health care professionals have been compet-
ing for territory, as illustrated by the following quote:
‘There has of course been a huge battle and from the point
of view of the professional association of dermatologists, so
that we are also able to prescribe it…and essentially, we
would very much like to keep it to ourselves, this vaccine,
because…it is us that deal with warts’ (DERM, 48).
Furthermore, participants from different specialties
claimed expertise and advocated their own role in deal-
ing with HPV and the HPV vaccine. The distrust be-
tween gynecologists and pediatricians was especially
prominent. Specifically, pediatricians argued they are the
only ones regularly dealing with vaccines as well as
receiving and treating patients of the appropriate age
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groups: ‘Vaccinations are not in the area of gynecologists
and obstetricians. And so they say ‘leave it and we will
see…let us have some more years of experience and we
will see’. They don’t do much reading. I am really sorry
to say this but pediatricians are the most informed
doctors. They are well read, (they know) all the results of
the multi-center studies that have been conducted…they
are alert…to convince parents that they should do it
(PED, 65) compared to gynecologists: ‘Those of course,
that administered it profusely, without even knowing
what it is, are gynecologists! Who have no clue about
vaccines!’ (PED, 55). Furthermore, gynecologists argued
that they are more qualified as they are in a position to
diagnose and treat cervical cancer: ‘It certainly falls into
the gynecologist’s area!....The pediatrician is more…
addicted to vaccinations!’ (GYN, 65).
In certain cases, participants realized the limitations of
their own role: ‘Vaccines, although one could say that, as
a subject, it is an infectious disease subject, that’s where
they belong, but, in order to be applied, they should be
given to primary care doctors who come in contact with
the public’ (ID, 40). Conversely, pharmacists and general
practitioners who are routinely asked for their advice
by members of the public, within the context of a long-
term and trusted relationship, expressed the desire for
an enhanced role so that they can respond in a respon-
sible manner.
Health professionals’ perceptions of the public’s attitudes
Participants mentioned a number of different causal
factors in an attempt to interpret the low levels of
vaccination coverage in Greece. The majority thought
the public’s negative attitude is not unique to the
HPV vaccine: ‘I believe that, in Greece, there is generally…
public ignorance and a hesitancy towards vaccinations.
There is a belief that vaccinations are commercial products
of multi-nationals and are designed to bring profit to
certain companies and that vaccinations are harmful and
anyhow…And sometimes it is difficult to “sell” a vaccine to
a patient because vaccinations are meant to be seen from
the point of view of community protection rather than
individual patient protection’ (ID,40). To substantiate this
claim, participants stated that the Greek public also
treated the swine flu vaccinations with suspiciousness in
2010. Despite recommendations by KELPNOO (Hellenic
Center for Diseases Control and Prevention) and several
appeals made to the public, voluntary turnout was very
low. Some participants speculated that this negative
attitude towards vaccinations might be rooted in the
Greek culture and hence encountered repeatedly: ‘I believe
in two factors, in the innate fear of the Greek population of
everything new – as far as vaccinations are concerned-…,
and also insufficient information….both from the media, if
you like, but also from us doctors…to this population’
(ID,53).
Other participants thought that the public’s attitudes
might be affected by health professionals’ attitudes to-
wards the HPV vaccine: ‘I believe that this reaction by
parents, is supported by the refusal of many health
professionals.’ (ID,47) or might be mirroring health pro-
fessionals’ attitudes: ‘…the public’s distrust we observe …
reflects the doctors’ distrust!’ (PED,65). Participants
thought that this alone can justify low vaccination rates:
‘Doctors are not convinced yet, I guess, otherwise they
would (prescribe)…this is up to the doctor’ (PH,58). Ac-
cording to participants this was also the case for H1N1
vaccinations: ‘Η1Ν1, this flu caused a lot of damage.
Because the public thought that this was a profit
making game, that Greece obtained a lot of vaccines,
towards which there was distrust…from the medical
world, as very few hospital doctors and nursing staff
actually got vaccinated. So when the medical world,
does not accept something…how will (the public)?…not
many children were vaccinated… because doctors
were not convinced for the need for mass vaccination’
(PED, 65).
Participants also thought that the public suffered from
a lack of reliable information or even misinformation
mainly due to the fact that the source is traditional
media and the internet. Although they distinguished
between traditional media and the internet in terms of
credibility: ‘I have not seen inaccuracies in the press…In
the internet…things are out of control!’ (GYN, 50), they
judged this to be problematic because the views expressed
via the media can be either positive or negative and could
very well shape the public’s reserved attitude towards
vaccinations and enhance their resistance to health profes-
sionals’ recommendations: ‘If someone googles it…he/she
will see thousands of things against the vaccine. It will
certainly affect… (public’s attitudes)…because nowadays
people perform thorough searches on the internet. But they
cannot be selective about the information that is offered to
them. So if they read it is has been connected with, I don’t
know, autism, neurological diseases, they will think ‘why
perform a vaccination when my child does not have sexual
intercourse?’ (ID, 47).
Participants also highlighted that the Greek family is
quite conservative and overprotective which has a
number of implications. Specifically, parents are unwill-
ing to openly discuss sexual safety because they refuse
to accept the fact that their daughter might be having
sexual relations. Therefore, this issue is not addressed
early enough: ‘You essentially miss the critical time
period… A mother must be very aware and progressive
to consider the fact that her 14-year old daughter will
have her sexual debut soon, so that she arranges a visit
to the gynecologist’ (ID,47).
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Health professionals were aware that the target popu-
lation namely teenagers are unique in the sense that
they are not very knowledgeable or careful about health
issues: ‘Youth is combined with carelessness about
health issues…you are invulnerable, yes. And this is
absolutely normal. A normal mentality’ (ID, 47). How-
ever, they thought that being vaccinated against HPV
will not make teenagers prone to riskier sexual behav-
ior. This is mainly due to the fact that teenagers may
not be aware of HPV since it is a relatively new ‘scare’
while other STDs and specifically HIV have already
shaped behavior such as condom use: ‘I believe that
children who do not take precautions think about STDs
such as syphilis, herpes, vaginal infections…and every-
thing else transmitted sexually. I don’t think that all
children know, when they are about to have sexual
intercourse, about the HPV virus. This is the last
concern. In general they are afraid of AIDS, the other
sexual, infectious STDs, unfortunately there are inci-
dents. So, it is unlikely that they preoccupy themselves
with cancer since AIDS dominates’ (PED, 65).
Health professionals’ perceptions of the role of the state
Participants raised a number of issues with regards to the
current health on the HPV vaccination policy adopted by
the Greek state. Firstly, that the lack of financial resources
has shaped this policy to a large extent (i.e. vaccine offered
only to girls, no school vaccination program in place, lack
of walk-in clinics for STD testing etc). Furthermore, that
this policy allows for a serious ‘gap’ in vaccination as
health services attendance of girls between 14–25 years of
age is minimal due to the fact that these girls have stopped
visiting their pediatrician but have not yet paid their first
visit to the gynecologist. In addition, they reported that
they all suffered from lack of guidance from the Ministry
of Health and the state with regards to prescription,
administration and mode of delivery (i.e. medical special-
ties entitled to prescribe the vaccine, recommended age
range, conditions of prescription e.g. before or before and
after sexual debut, before or after a HPV DNA test, insur-
ance funds covering the cost etc.). As illustrated by one
participant: ‘The ministry in Greece, unfortunately for all
issues, sends circulars, which are communicated in print to
the responsible structures but in the end never reach the
practitioner’ (ID, 40).
Further to this, participants had expectations that they
would be supplied with uniform information, materials
and resources as: ‘It goes without saying that the ministry
is the one that will direct efforts’ (DERM, 48). Further to
health professionals’ lack of relevant information, partici-
pants believed that the public also suffered from lack of
information since none recalled a nationwide state initia-
tive or state run campaign for cervical cancer prevention
(i.e. screening, vaccination) or a sexual health education
campaign targeting teenagers. Finally, the role of the
state, as seen by participants, is to actively coordinate
efforts in order to achieve large scale immunity: ‘Since
the ministry and the department of public health, have a
bigger financial capacity than any private or smaller
organization…to regulate something, launch or promote
something…a huge social organization, which is inde-
pendent and formal’ (GYN, 43).
Health professionals’ perceptions of their own role
The majority of participants were of the opinion that
not only is it within the physicians’ role but rather it is
their duty to inform members of the target group about
the HPV vaccination and subsequently administer it,
irrespective of any personal concerns they might have.
As one participant put it: ‘I believe that, medicine in this
day and age is not a science where everybody can do
what they want. It is a science! And someone who is
practicing medicine ought to respect the rules and the
medical stance of this time. And the stance now is to
administer the vaccine’ (ID, 40). Some participants
would be willing to extend their role in HPV vaccination
or even accept a new role, such as pharmacists who can
currently only administer the vaccine upon receipt of a
physician’s prescription: ‘We wish that we pharmacists
had this type of responsibilities, to do such a thing
(inform)…but as things are today…the system…it is the
doctor who is entitled’ (PH, 34).
However, not all participants agreed on whether basic
sex education is within the physician’s role. Some thought
it best to provide at least some context to the HPV vaccin-
ation: ‘I consider it to be part of my job. Because my job is
not tertiary…at tertiary level, in an intensive care unit. My
job involves mainly prevention. In my primary care office’
(GYN, 50), while others thought that this was the respon-
sibility of the parent or the state: ‘These are things that…
the doctor cannot do. It is not the doctor’s job to do such a
thing. It is not mine either…will I conduct sexual education
for my patients? I will do it for my child, not my patient!
(DERM, 48).
Participants’ views converged in that sexual education
in Greece is either non-existent or badly conducted
partly due to the fact that no-one is clear about whose
responsibility it is (i.e. school, family or health profes-
sional). All participants agreed that sexual health in-
formation should definitely be offered as part of a
continuous school sexual health program so that that
every child receives the same information via a trust-
worthy source such as a school physician or nurse, an
institution currently abolished: ‘There is no medical
service at schools…in the past there was a medical
service, there were doctors, responsible for talking to
kids…and the parents, they were invited, but now I don’t
know who will be burdened with this engagement, this
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additional engagement. And there is some resentment,
in the medical world due to severe cuts that our sal-
aries have suffered…. (PED, 65), rather than being left
to non-expert individual initiatives: ‘I had an experi-
ence, whereby a biology teacher said….(to the school-
children) “you don’t need to have it, because you will
damage your health…find a person who will only be
with you and you will only come in contact with him
all your life so you will be fully covered”’ (GYN, 50).
Discussion
Findings of the present study indicated that participants
recognized the HPV vaccine as a major health innovation.
However, they had certain concerns with regards to its
safety, effectiveness and impact of long term use. A recent
study investigating physicians’ intentions to vaccinate girls
at the recommended age range, found that these inten-
tions were largely influenced by subjective norms (i.e.
recommendations given to them as appropriate clinical
practice) [23]. Specifically, that physicians tended to agree
with recommendations of esteemed colleagues, profes-
sional organizations etc. The authors concluded that when
new practices such as technological health innovations are
introduced it is imperative for physicians to receive guid-
ance and recommendations by their professional bodies
and/ or the state. These findings are especially relevant to
countries that have not introduced school based vaccin-
ation programs but rather rely on health professionals’
recommendations for vaccination, such as Greece. Further
to this, current findings revealed that the HPV vaccine has
given rise to a great amount of animosity among health
professionals from various medical specialties. The lack of
inter-professional respect within health care settings is a
well documented phenomenon which regrettably is likely
to increase the public’s distress and can compromise its
safety [24].
A number of studies have suggested that health pro-
fessionals need to be supported in their role of initiating
a discussion about HPV, offering vaccination and arriv-
ing at a shared decision with their patients [25, 26]. A
large part of this process would involve eliciting percep-
tions and addressing concerns with the help of good
informational resources [14]. Health professionals in the
present study felt the need to inform their patients in a
responsible manner, however lacking in guidance, infor-
mation and resources. This finding is in line with that of
a previous study [27] investigating the experiences of
UK school nurses during the first year of the HPV
school vaccination program. School nurses reported that,
at the start of the program in 2008, they felt unprepared
as they had not received enough training beforehand and
attributed this to lack of planning on the part of the policy
makers.
Certain interventions aiming to support health profes-
sionals have been proposed in the literature. Specifically,
one Irish study suggested the use of an intervention
within the context of which a range of factors found to
influence HPV related clinical behaviors are addressed.
Such factors include beliefs about consequences, know-
ledge, emotion and social influences [25]. Another
Canadian study investigated the use of decision boxes
namely tools offering guidance to clinicians with regards
to communicating evidence-based information to patients,
exploring patients’ values and preferences in management
options to support a shared decision-making process
regarding ‘medical questions that have no single best
answer’ [26]. Prototypes of these decision making tools,
available both in print and online, were evaluated by both
physicians and patients via focus group discussions and
modified accordingly to include issues of interest such
as benefit and harm of an intervention, list of questions
to ask the health professional etc. HPV vaccination was
among the clinical topics suggested by health profes-
sionals as suitable for this approach.
Some health professionals in the current study believed
that talking about sexual health to adolescents in the con-
text of a visit was outside their medical role. In contrast,
findings of a similar previous study suggested that pedia-
tricians, general practice physicians and family practice
physicians were willing to discuss sexual health issues
with their young patients using HPV vaccination as
an opportunity [28]. However, once again the importance
of supporting physicians in order to conduct these conver-
sations is highly stressed. The authors suggest that sup-
port can take the form of skills training to help physicians
build rapport, elicit information regarding the patient’s
behavior, give information in age-appropriate ways, assess
the relevance and importance of said topics to individual
patients etc.
Finally, none of the participants of the present study
could recall a state run health promotion campaign with
regards to HPV and cervical cancer. According to WHO,
public knowledge about cervical cancer and its association
with HPV can be improved via the use of community edu-
cation campaigns, a solid strategy for increasing vaccine
acceptance [2]. Furthermore, it is highlighted that the
information/ education messages should be tailored to the
local cultural context and needs of the target population
(i.e. adolescents and young adults) but also to the needs of
parents or guardians, educators, community leaders and
health-care providers. A recent US study evaluated a
social marketing campaign aiming to raise awareness
among parents with regards to HPV vaccination [29]. The
campaign which addressed perceptions of susceptibility to
HPV infection, severity of cervical cancer, benefits of
vaccination as well as barriers to vaccination such as
safety, efficacy, cost and access was planned, implemented
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and evaluated by communication and public health
experts. Within the context of the campaign, HPV
vaccination material was placed in medical settings
for providers to use when discussing this issue with
patients. The majority of providers used the campaign
brochures and thought the campaign influenced parents’
decisions to get their daughters vaccinated against HPV.
The campaign was deemed successful after the moni-
toring of the campaign’s website, hotline calls, public
services announcements, cross-sectional surveys and
immunization rates [29].
This study’s findings need to be interpreted with cau-
tion as purposeful sampling was employed. The sample
was not representative of Greek health professionals as a
whole, but rather was selected to include participants
from a range of relevant medical specialties and institu-
tions. Findings have highlighted some important issues
in current practice, which could be investigated further
in future qualitative and quantitative research. Moreover,
findings have led to the formulation of practice and policy
recommendations.
The successful introduction and acceptance of the
HPV vaccines will depend on a range of factors includ-
ing public knowledge, attitudes towards the vaccine
and health information communication. The prevention,
screening and treatment of the HPV virus and cervical
cancer constitute an area requiring the input of multiple
disciplines both in terms of research and practice. Firstly,
the state needs to make available a policy document, out-
lining the rationale of evidence-based recommendations
leading towards a clear public health goal. Furthermore,
multi-disciplinary expert groups need to be established,
comprising of all disciplines relating to the issue of HPV
vaccination, in order to develop guidelines and protocols
for health care professionals with regards to informing
patients, screening for eligibility, suggesting vaccination,
prescribing, vaccinating, performing follow- ups etc. It has
been suggested in the literature that in some cases profes-
sionals’ own knowledge will not be sufficient to cover
patients’ informational needs and deal with their concerns
[30]. Therefore, health professionals need to be supported
through various educational initiatives which will help
them communicate health information effectively while
respectfully considering patients’ perspectives. Further-
more, health professionals also need to be given access to
the latest medical research developments, as well as
provided with support tools (e.g. a structured approach to
communicating vaccination information according to pa-
tients’ readiness to vaccinate) [14], shared decision making
tools (e.g. decision boxes for medical issues with no single
best answer) [26] etc.
Currently underutilized resources need to be identified
and exploited such as community pharmacists, who fre-
quently constitute the first port of call for health related
inquiries. Their frequent contact with the public can allow
them to take on new roles such as infection prevention
[31]. Moreover, the institution of school nurses and doctors
needs to be re-introduced, a change which will further
reinforce the school’s role as a health promotion setting.
With their input, sexual health education can be taught
and sexual promotion programs can be carried out on a
permanent basis. According to the CDC, nurses can play a
major role in preventive health care and to this end has
produced educational material for them to use to educate
parents and talk to adolescents [32]. In conclusion, the
introduction of the HPV vaccine as a public health effort
needs to be closely monitored and further research needs
to be conducted to assess its effectiveness and impact.
Conclusions
This study constitutes a mapping of Greek health profes-
sionals’ perceptions of the HPV vaccine, state policy rec-
ommendations and their own role. One of the major
emerging issues is the fact that there are no established,
effective communication channels among the various
professional bodies, between state institutions and health
professionals or among the different relevant medical
specialties. Another major issue identified is that the
state policy as it currently stands lacks clarity. With no
school vaccination program in place, health professionals
have been assigned the responsibility to inform, prescribe
and administer the HPV vaccine to the target population.
However, the state has not provided guidance, information
or resources. The impact of this lack of effort coordination
is twofold: firstly, health professionals’ concerns, lack of
role definition and uniform information provision have
led to territorial disputes among professional bodies and
distrust among different medical specialties. Secondly,
positive and negative judgments deriving from a multitude
of sources have resulted in the confusion of the general
public, as manifested by low vaccination coverage rates.
Due to the lack of clear regulation of vaccination prescrip-
tion, administration and mode of delivery, factors such as
lack of knowledge, cultural beliefs and personal attitudes
have shaped the vaccination landscape. These factors have
neither been explored nor addressed prior to the initiation
of this public health effort and as such there is an evident
less than efficient use of resources. Some of the issues de-
scribed in this paper could be relevant to other European
countries which have also adopted ‘on demand’ HPV
vaccination schemes or are currently considering an HPV
vaccination policy.
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